Comparison of subcutaneous analgesic system and epidural analgesia for postoperative pain control in open pediatric

Steven C Mehl1, Brittany Johnson2, Nihar Patel3

  • 1Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, United States; Department of Surgery, Division of Pediatric Surgery, Texas Children's Hospital, Houston, TX, United States.

Insights

Epidural analgesia provided better early pain control for pediatric cancer surgery patients, but surgeon-placed subcutaneous analgesic systems (SAS) showed fewer complications. Both methods achieved high parental satisfaction, making SAS a viable alternative.

Area of Science:

  • Pediatric Surgery
  • Oncology
  • Pain Management
  • Anesthesiology

Background:

  • Post-operative pain is a significant concern for children undergoing open oncologic surgery.
  • Effective pain management strategies are crucial for recovery and patient well-being.

Purpose of the Study:

  • To compare the efficacy and safety of a surgeon-placed subcutaneous analgesic system (SAS) versus epidural analgesia for managing post-operative pain in pediatric patients.
  • To evaluate pain scores, analgesic requirements, clinical outcomes, and parental satisfaction.

Main Methods:

  • A single-center randomized controlled trial involving 36 children (≤18 years) undergoing open tumor resection.
  • Patients were randomized preoperatively to either SAS or epidural analgesia.
  • Perioperative pain management was standardized, and families were blinded to the treatment modality.

Main Results:

  • The epidural group demonstrated significantly lower oral morphine equivalent (OME) demand on postoperative days one and two.
  • Pain scores were comparable between the SAS and epidural groups across the first three postoperative days.
  • The epidural group experienced a higher incidence of device complications and urinary catheter use compared to the SAS group.

Conclusions:

  • Epidural analgesia appears superior for early post-operative pain control in children undergoing major oncologic surgery.
  • Subcutaneous analgesic systems (SAS) offer a favorable safety profile with fewer device complications and reduced urinary catheter use.
  • Both SAS and epidural analgesia result in excellent parental satisfaction, positioning SAS as a potential alternative, particularly when epidural placement is not feasible.
Abstract

Related Concept Videos

Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
484
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
384
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
753
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
731
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
185
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia01:30

Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia

Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
1.2K